Strides Arcolab Receives FDA Approval to Market Product

One of India’s leading drug manufacturers, Strides Arcolab has revealed that it has received approval from the US Food and Drug Administrator to market its first liquid injection sterile product that is currently being manufacturer at its new facility in Bangalore.

The company confirmed through a press statement that it has received the permission to commercially market the product but added that it was unable to disclose the name of the product due to a confidentiality agreement.

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.

Confirming the statement, the CEO of Agila Specialties, a wholly-owned specialities division of Strides Arcolab, Venkat Iyer said, “The USFDA approval for the product from the new site will go a long way in ameliorating product shortages in the critical therapeutic areas. Two significant product approvals from the new facility augur well for the launch of a series of products in the USA during 2011.”

Share prices of Strides Arcolab shot up to an intra-day high of Rs 397.85 before settling down to Rs 388.50, up by 1.16 per cent, on the Bombay Stock Exchange.

Source-Medindia

Oral Cancer | Mouth Cancer - Types, Causes, Symptoms, Diagnosis, Treatment & Prevention
Oral cancer is a cancer that develops in any part of the mouth. It is more common in men over 40.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.